ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ONC vs GMAB // DIVIDEND YIELD & FCF PAYOUT SAFETY

BeOne Medicines Ltd. (NASDAQ) VS. Genmab A/S ADS (NASDAQ) • 15-METRIC TALLY: ONC 6 — GMAB 6
■ METRIC PARITY
dividend-safety
0.00%
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ONC VS. GMAB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ONC GMAB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 87.50% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.50% 9.90% +0.60 ONC /roic <GO>
EV/EBITDA & P/E Valuation 63.9x 21.0x +42.90 GMAB /valuation <GO>
Free Cash Flow Yield 2.23% 2.21% +0.02 ONC /fcf-yield <GO>
Operating Margin 8.40% 13.90% -5.50 GMAB /operating-margins <GO>
Net Profit Margin 5.40% 10.90% -5.50 GMAB /net-margins <GO>
Revenue Growth (YoY) 40.20% 22.00% +18.20 ONC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.68 3.74 +2.94 ONC /balance-sheet <GO>
Piotroski F-Score Quality 9/9 8/9 +1.00 ONC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.6 85.2 -31.60 GMAB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.98 1.09 -0.11 GMAB /macro-sensitivity <GO>
Forward P/E Multiple 123.6x 27.6x +96.00 GMAB /forward-pe <GO>
Enterprise Scale & Market Cap $42.25B $35.25B $6.99B ONC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ONC REV GMAB REV ONC GROSS % GMAB GROSS % ONC FCF GMAB FCF
FY 2025 $5.34B — 87.5% — $941.7M —
FY 2024 $3.81B — 84.4% — -$633.3M —
FY 2023 $2.46B — — — -$1.27B —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ONC // BETA 0.98
GMAB // BETA 1.09